CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹23,249 Cr | ₹19,392 Cr | ₹16,805 Cr | ₹14,711 Cr | ₹13,181 Cr |
What is the latest Total Current Assets ratio of CIPLA ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹23,249 Cr |
| Mar2024 | ₹19,392 Cr |
| Mar2023 | ₹16,805 Cr |
| Mar2022 | ₹14,711 Cr |
| Mar2021 | ₹13,181 Cr |
How is Total Current Assets of CIPLA Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹23,249 Cr | 19.89 | |
| Mar2024 | ₹19,392 Cr | 15.40 | |
| Mar2023 | ₹16,805 Cr | 14.24 | |
| Mar2022 | ₹14,711 Cr | 11.61 | |
| Mar2021 | ₹13,181 Cr | - | |
Compare Total Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹121,577.9 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,491.0 Cr | 0.8% | -3% | -26.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.8% |
-1.2% |
1.4% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses